Prudential Financial Inc Cassava Sciences Inc Transaction History

Prudential Financial Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$36.77 - $90.91 $123,547 - $305,457	-3,360 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $15,253 - $49,384	365 Added 12.19%	3,360 $209,000
Q2 2021 Aug 16, 2021	BUY	$32.15 - $89.72 $96,289 - $268,711	2,995 New	2,995 $256,000

205

13.9M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $113M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.